Method for appealing and reporting medical circulation data

Through mobile device and natural language processing technology, the problems of abnormal and low processing efficiency of medical circulation data during the flow process are solved, accurate management and efficient complaint processing of drug information are achieved, and data quality and circulation efficiency are improved.

CN118917801AInactive Publication Date: 2024-11-08北京健易保科技有限公司
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411008005.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-25
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

There are problems of data abnormalities and low processing efficiency in the flow process of medical circulation data. The existing complaint reporting process is cumbersome and information transmission is opaque, resulting in low processing efficiency and information errors.

Method used

Data entry and appeal reporting functions are provided through the mobile device, and drug circulation management module is used to record drug information in real time, and appeal review is carried out in combination with natural language processing technology to ensure data accuracy and processing efficiency.

Benefits of technology

It improves the efficiency and accuracy of data updates, ensures accurate management and rapid update of drug information, and realizes efficient complaint handling and data quality control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118917801A_ABST
    Figure CN118917801A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of information, in particular to a medical circulation data appeal submission method, which comprises the following detailed steps that: S1, a data provider provides services for manufacturers, wholesale enterprises, retail enterprises and medical institutions through a mobile equipment terminal; and S2, a manufacturer inputs a medicine name through an information input unit in the mobile equipment terminal, a searchable entry is generated in a medicine circulation management module, and a data provider obtains data, perfects entry information and pushes the entry information to the medicine circulation management module. The efficiency and accuracy of data updating are greatly improved, the accuracy and reliability of medicine circulation data are guaranteed, the appeal text is efficiently processed through the appeal auditing module, the appeal processing efficiency and accuracy are improved, the appeal is allocated to the special auditing personnel of the corresponding problem category, and the efficiency and accuracy of data updating are improved. Rapid updating and accurate management of the medicine circulation data are realized, and the method is of great significance to data management and quality control in the field of medicine circulation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of information technology, and specifically relates to a method for submitting complaints about pharmaceutical circulation data. Background Art

[0002] Pharmaceutical circulation data mainly comes from various links in the pharmaceutical circulation industry, including pharmaceutical wholesale, pharmaceutical retail, and third-party logistics. These data involve the entire circulation process from pharmaceutical manufacturers to sales terminals and then to consumers. Pharmaceutical circulation data contains rich information, including but not limited to the procurement, sales, inventory, price, and logistics of drugs. Specifically, it includes drug flow analysis, sales, sales share, terminal contribution ranking data, and competitive product analysis, market share, and sales status warning market competition-related information. Since the pharmaceutical circulation link itself is a nonlinear multi-level network structure, pharmaceutical circulation data also presents scattered and chaotic characteristics. There will be data anomalies in the circulation data, or anomalies will occur during the analysis of the circulation data. It is necessary to manually file complaints against various abnormal data offline. The existing complaint submission process is relatively cumbersome and involves multiple departments or links, resulting in inefficient problem handling. There may be unnecessary steps or links in the process, which increases processing time and cost. In the complaint submission process, the transmission and sharing of information is not transparent enough, resulting in the inability of relevant parties to timely understand the progress and results of problem handling. There is a lack of a unified information platform or system, which may cause errors or omissions when information is transmitted between departments. In this regard, we propose a method for reporting pharmaceutical circulation data complaints. Summary of the invention

[0003] In view of the deficiencies in the prior art, the present invention provides a method for submitting complaints about pharmaceutical circulation data to solve the above technical problems.

[0004] To achieve the above-mentioned purpose, the present invention provides the following technical solution: a method for submitting a complaint about pharmaceutical circulation data, wherein the detailed steps of the method for submitting a complaint are as follows:

[0005] S1. Data providers provide services to manufacturers, wholesalers, retailers, and medical institutions through mobile devices;

[0006] S2. The manufacturer enters the drug name through the information entry unit in the mobile device, and generates a searchable entry in the medicine circulation management module. After the data provider obtains the data, it completes the entry information and pushes it to the medicine circulation management module;

[0007] S3, the medicine circulation management module records the information of medicines entering and leaving the warehouse, purchasing information, and sales information, and modifies the entry information data of medicines in real time;

[0008] S4. Manufacturers, wholesalers, retailers, and medical institutions can file complaints through the complaint reporting unit on mobile devices if they discover information errors during the drug distribution process.

[0009] S5. After receiving the complaint report, the complaint review module will conduct a preliminary review of the complaint report to determine whether there are any errors in the basic information of the complaint, and then transfer the complaint report information to the reviewer of the data provider according to the category. After verifying the complaint report information, the reviewer will modify the drug entry information data and send a receipt to the mobile device of the initiator of the complaint.

[0010] Preferably, the entry information of the drug is unique in the medicine circulation management module.

[0011] Preferably, in step S3, the Chinese medicine circulation management module obtains information by connecting with the manufacturer's warehousing and distribution system, the procurement platform system and the sales systems of sellers at all levels.

[0012] Preferably, the specific steps of filing a complaint in step S4 are:

[0013] A1. Enter the complaint submission unit on the mobile device;

[0014] A2. Search and select the drug terms that need to be appealed. You can select multiple terms.

[0015] A3. Select the specific type of complaint from the general category of complaints;

[0016] A4. Describe the problem in detail in the complaint description window;

[0017] A5. Upload the attachment of the appeal certificate;

[0018] A6. Fill in the contact information and click on Report Complaint.

[0019] Preferably, the method of review by the appeal review module in step S5 is:

[0020] B1. Pre-process the text information of the complaint submission;

[0021] B2. Use natural language processing technology to extract key information from the complaint text;

[0022] B3. Compare the extracted key information with the data in the medicine circulation management module;

[0023] B4. Based on the comparison results, determine whether the key information in the complaint is consistent with the existing information or whether there are discrepancies.

[0024] Preferably, the steps of extracting key information from the complaint text using natural language processing technology are: collecting the complaint text as a data set, removing noise in the text, including but not limited to HTML tags, special characters, and URLs, using word segmentation tools and part-of-speech tagging tools to segment and tag the text, removing common words and meaningless words in the text, using named entity recognition methods to identify key entities in the text, and using a word vector model to extract keywords from the text.

[0025] Preferably, the named entity recognition method identifies named entities by defining rule modules and generating dictionaries through collecting relevant vocabulary information in medical circulation. It is necessary to construct rule templates based on the structure and characteristics of the language. The features selected in the rule templates include statistical information, punctuation marks, keywords, indicator words, directional words, position words and central words. The rule templates mainly use pattern and string matching as the main means to identify potential named entities from text.

[0026] Preferably, the word vector model chooses to use the CBOW model, which requires selecting words from the text as input samples, converting the target words and context words into corresponding word vectors, converting the vectors into real number vector representations through linear transformation, and constructing the CBOW model using a two-layer fully connected neural network structure.

[0027] Preferably, in step B4, the appeal review module compares the existing pharmaceutical circulation data. If the appeal modification data is consistent with the existing data, the appeal will be rejected and the reason will be fed back. If there is a discrepancy, it will be assigned to the special reviewer of the corresponding problem category for review.

[0028] Preferably, after the mobile data terminal submits the appeal, the account initiating the appeal follows up the processing progress in real time.

[0029] Compared with the prior art, the present invention has the following beneficial effects:

[0030] This application enables manufacturers, wholesalers, retailers, and medical institutions to participate in data management quickly and easily through mobile devices, greatly improving the efficiency and accuracy of data updates. The pharmaceutical distribution management module records the warehousing, procurement, and sales information of drugs in real time, and provides a complaint submission function through mobile devices to ensure that data errors can be quickly discovered and corrected, thereby ensuring the accuracy and reliability of pharmaceutical distribution data. The efficient processing of complaint texts using the complaint review module improves the efficiency and accuracy of complaint processing, and assigns complaints to special reviewers of the corresponding problem category, ensuring that complaints can be handled professionally and promptly, achieving rapid updating of pharmaceutical distribution data, accurate management, and efficient complaint processing, which is of great significance to data management and quality control in the field of pharmaceutical distribution. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 This is a flow chart of the method for submitting complaints about pharmaceutical distribution data. DETAILED DESCRIPTION

[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] The present invention provides a technical solution: a method for submitting complaints about pharmaceutical circulation data. The detailed steps of the method for submitting complaints are as follows:

[0034] S1. Data providers provide services to manufacturers, wholesalers, retailers, and medical institutions through mobile devices;

[0035] S2. The manufacturer enters the drug name through the information entry unit in the mobile device, and generates a searchable entry in the medicine circulation management module. After the data provider obtains the data, it completes the entry information and pushes it to the medicine circulation management module;

[0036] S3, the medicine circulation management module records the information of medicines entering and leaving the warehouse, purchasing information, and sales information, and modifies the entry information data of medicines in real time;

[0037] S4. Manufacturers, wholesalers, retailers, and medical institutions can file complaints through the complaint reporting unit on mobile devices if they discover information errors during the drug distribution process.

[0038] S5. After receiving the complaint report, the complaint review module will conduct a preliminary review of the complaint report to determine whether there are any errors in the basic information of the complaint, and then transfer the complaint report information to the reviewer of the data provider according to the category. After verifying the complaint report information, the reviewer will modify the drug entry information data and send a receipt to the mobile device of the initiator of the complaint.

[0039] Furthermore, the uniqueness of drug entry information in the pharmaceutical circulation management module ensures the accuracy and consistency of pharmaceutical circulation data. In the process of pharmaceutical circulation, the identification, traceability and management of drugs rely on accurate and consistent information. The non-uniqueness of drug entry information will lead to data confusion, repeated entry and information conflict, which will in turn affect the decision-making and management of drug procurement, sales and inventory links, help to improve the efficiency of pharmaceutical circulation management, ensure the quality and safety of drugs, and enable the pharmaceutical circulation management module to track the flow, inventory and use of drugs in real time, and promptly discover abnormal situations of drugs, so as to take corresponding measures to deal with them, provide strong support for the recall and traceability of drugs, and ensure the quality and safety of drugs.

[0040] Furthermore, in step S3, the Chinese medicine circulation management module obtains information by connecting with the manufacturer's warehousing and out-of-warehouse system, the procurement platform system and the sales systems of various layers of sellers. It is connected with the manufacturer's warehousing and out-of-warehouse system so that the medicine circulation management module can obtain the warehousing and out-of-warehouse information of the drugs in real time, which is very important for inventory management and supply chain optimization. It monitors the inventory status of the drugs in real time and adjusts the procurement and sales strategies in time to avoid inventory backlogs or out-of-stock situations. It enables the medicine circulation management module to obtain the procurement information of the drugs, effectively manage the procurement activities, ensure that the purchased drugs meet the quality requirements, optimize the procurement costs, and connect with the sales systems of various layers of sellers. The data service provider can obtain the sales data of the drugs, analyze the sales data, understand the market demand and competitive situation, provide strong support for the formulation of sales strategies, predict future sales trends, and provide guidance for inventory management and procurement plans.

[0041] Furthermore, the specific steps of filing a complaint in step S4 are:

[0042] A1. Enter the complaint submission unit on the mobile device;

[0043] A2. Search and select the drug terms that need to be appealed. You can select multiple terms.

[0044] A3. Select the specific type of complaint from the general category of complaints;

[0045] A4. Describe the problem in detail in the complaint description window;

[0046] A5. Upload the attachment of the appeal certificate;

[0047] A6. Fill in the contact information and click Report Complaint;

[0048] The complaint submission method ensures that complaint information is submitted in accordance with the established format and structure, which simplifies the information processing process. Through standardized information input, the system can identify key information more quickly, reduce the time for manual screening and sorting, and improve processing efficiency. It provides clear guidance, lowers the threshold and difficulty for users to submit complaints, helps users better express their demands, reduces communication barriers caused by incomplete information or incorrect formats, and makes complaint data more standardized and structured, facilitating subsequent data analysis and mining. By analyzing complaint data, we can understand the main demands and concerns, provide strong support for improving products and services, and provide decision-making basis for the subsequent discovery of potential problems and trends and the continuous optimization of the complaint mechanism.

[0049] Furthermore, the method of review by the appeal review module in step S5 is:

[0050] B1. Preprocess the text information of the complaint submission, including removing noise and irrelevant information from the text, discovering and correcting spelling errors, grammatical errors or other text errors, filling missing values, converting all text to lowercase to reduce vocabulary diversity, deleting common words that do not contribute much to the meaning of the text, performing stemming and morphological restoration, and segmenting continuous text into independent words or phrases;

[0051] B2. Use natural language processing technology to extract key information from the complaint text;

[0052] B3. Compare the extracted key information with the data in the medicine circulation management module;

[0053] B4. Based on the comparison results, determine whether the key information in the complaint is consistent with the existing information or whether there are discrepancies.

[0054] Furthermore, the steps of extracting key information from the complaint text using natural language processing technology are as follows: collecting the complaint text as a data set, removing HTML tags, special characters, and URLs from the text, using word segmentation tools and part-of-speech tagging tools to segment and tag the text, removing common words and meaningless words from the text, using named entity recognition methods to identify key entities in the text, and using word vector models to extract keywords from the text. Natural language processing technology includes two major parts: natural language understanding and natural language generation. The word vector model is a method used in natural language processing to represent vocabulary as numerical vectors, so that computers can understand and process natural language text data to perform various natural language processing tasks, including but not limited to text classification, sentiment analysis, and machine translation. Named entity recognition identifies entities with specific meanings from the text and classifies them into predefined categories. The main tasks of named entity recognition include determining the starting and ending positions of named entities in the text and determining the class to which the identified named entities belong.

[0055] Furthermore, the named entity recognition method defines rule modules and generates dictionaries to identify named entities by collecting relevant vocabulary information in medical circulation. It is necessary to construct rule templates based on the structure and characteristics of the language. The features selected in the rule templates include statistical information, punctuation marks, keywords, indicator words, directional words, position words and central words. The rule template mainly uses pattern and string matching as the main means to identify potential named entities from the text. The rule-based method is a common and effective method in named entity recognition. It relies on manually defined rule templates and dictionaries to identify named entities. In the field of medical circulation, in order to construct such rule templates, we need to have an in-depth understanding of the language structure and characteristics of the medical field and select appropriate features accordingly.

[0056] Furthermore, the word vector model chooses to use the CBOW model, which requires selecting words from the text as input samples, converting the target words and context words into corresponding word vectors, converting the vectors into real vector representations through linear transformation, and using a two-layer fully connected neural network structure to build the CBOW model. The CBOW model is a neural network model for generating word vectors. Its core principle is to predict the central word itself based on the context of the central word. Compared with the traditional neural network language model, the CBOW model removes the nonlinear activation process of the hidden layer, directly performs linear summation on the input word vectors, and then performs a softmax operation on the output layer to obtain the probability distribution to predict the central word.

[0057] Furthermore, in step B4, the appeal review module is compared with the existing pharmaceutical circulation data. If the appeal modification data is consistent with the existing data, the appeal will be rejected and the reason will be fed back. If there is a discrepancy, it will be assigned to the special reviewer of the corresponding problem category for review. The reviewer will judge the correctness and rationality of the appeal based on the refined text of the appeal review module, the name of the drug and the attached complaint certificate. If there are any questions, the appellant will be directly contacted through the contact information left by the appellant, which improves the effectiveness and timeliness of communication and avoids the complexity and difficulty of communication caused by too many people involved in pharmaceutical circulation.

[0058] Furthermore, after submitting a complaint on the mobile data terminal, the account that initiated the complaint can follow up on the processing progress in real time to view the current status of its complaint, the estimated processing time, and any related system updates or notifications. When the user submits a complaint through the mobile data terminal, the system will generate a unique complaint number and send this number to the user. The user can use this number to enter it in the complaint submission unit of the mobile data terminal to query the detailed information and processing progress of its complaint. Through the function of real-time follow-up of the processing progress, the account that initiated the complaint can more conveniently understand the handling of the complaint, reduce unnecessary waiting and anxiety, and can improve the user's satisfaction and trust in the mobile data terminal service, and promote a good relationship between users and the platform.

[0059] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.

[0060] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A method for submitting complaints about pharmaceutical circulation data, characterized in that: The detailed steps for filing a complaint are as follows: S1. Data providers provide services to manufacturers, wholesalers, retailers, and medical institutions through mobile devices; S2. The manufacturer enters the drug name through the information entry unit in the mobile device, and generates a searchable entry in the medicine circulation management module. After the data provider obtains the data, it completes the entry information and pushes it to the medicine circulation management module; S3, the medicine circulation management module records the information of medicines in and out of warehouse, purchase information, and sales information, and modifies the entry information data of medicines in real time; S4. Manufacturers, wholesalers, retailers, and medical institutions can file complaints through the complaint reporting unit on mobile devices if they discover information errors during the drug distribution process. S5. After receiving the complaint report, the complaint review module will conduct a preliminary review of the complaint report to determine whether there are any errors in the basic information of the complaint, and then transfer the complaint report information to the reviewer of the data provider according to the category. After verifying the complaint report information, the reviewer will modify the drug entry information data and send a receipt to the mobile device of the initiator of the complaint.

2. The method for submitting a complaint regarding pharmaceutical circulation data according to claim 1, characterized in that: The entry information of drugs is unique in the pharmaceutical circulation management module.

3. The method for reporting drug circulation data complaints according to claim 1, characterized in that: In step S3, the Chinese medicine circulation management module obtains information by connecting with the manufacturer's warehousing and distribution system, the procurement platform system and the sales systems of sellers at all levels.

4. The method for submitting a complaint about pharmaceutical circulation data according to claim 1, characterized in that: The specific steps of filing a complaint in step S4 are: A1. Enter the complaint submission unit on the mobile device; A2. Search and select the drug terms that need to be appealed. You can select multiple terms. A3. Select the specific type of complaint from the general category of complaints; A4. Describe the problem in detail in the complaint description window; A5. Upload the attachment of the appeal certificate; A6. Fill in the contact information and click Report Complaint.

5. The method for submitting a complaint about pharmaceutical circulation data according to claim 1, characterized in that: The method of review by the appeal review module in step S5 is: B1. Pre-process the text information of the complaint submission; B2. Use natural language processing technology to extract key information from the complaint text; B3. Compare the extracted key information with the data in the medicine circulation management module; B4. Based on the comparison results, determine whether the key information in the complaint is consistent with the existing information or whether there are discrepancies.

6. The method for submitting a complaint about pharmaceutical circulation data according to claim 5, characterized in that: The steps of using natural language processing technology to extract key information from complaint texts are as follows: collect complaint texts as a data set, remove noise from the text, including but not limited to HTML tags, special characters, and URLs, use word segmentation tools and part-of-speech tagging tools to segment and tag the text, remove common words and meaningless words from the text, use named entity recognition methods to identify key entities in the text, and use word vector models to extract keywords from the text.

7. The method for reporting drug circulation data complaints according to claim 6, characterized in that: The named entity recognition method defines rule modules and generates dictionaries by collecting relevant vocabulary information in medical circulation to identify named entities. It is necessary to construct rule templates based on the structure and characteristics of the language. The features selected in the rule templates include statistical information, punctuation marks, keywords, indicator words, directional words, position words and central words. The rule templates mainly use pattern and string matching as the main means to identify potential named entities from the text.

8. The method for submitting a complaint regarding pharmaceutical circulation data according to claim 6, characterized in that: The word vector model uses the CBOW model. It is necessary to select words from the text as input samples, convert the target words and context words into corresponding word vectors, convert the vectors into real number vector representations through linear transformation, and use a two-layer fully connected neural network structure to build the CBOW model.

9. The method for submitting a complaint regarding pharmaceutical circulation data according to claim 5, characterized in that: In step B4, the appeal review module compares the existing pharmaceutical circulation data. If the appeal modification data is consistent with the existing data, the appeal will be rejected and the reason will be fed back. If there is a discrepancy, it will be assigned to the special reviewer of the corresponding problem category for review.

10. The method for submitting a complaint regarding pharmaceutical circulation data according to claim 1, characterized in that: After the mobile data terminal submits the appeal, the account that initiated the appeal will follow up the processing progress in real time.

Citation Information

Patent Citations

  • Off-site regulation method used for medicine circulation

    CN103198409A

  • Method and device for processing drug circulation data appeal file

    CN116841957A

  • Method and device for medical circulation data appeal submission

    CN116862529A

  • Medical concierge

    IN201914031175A

  • Lawful suit process through on-line system and its management process

    KR1020040111036A